title: [Prevention and control of respiratory tract infections in the network of Italian Centers for Cystic Fibrosis].
abstract: Infections caused by respiratory pathogens such as Burkholderia cepacia and Pseudomonas aeruginosa are associated with an increased morbidity and mortality in people affected by cystic fibrosis, the most common lethal genetic disease in Caucasian populations. Preventing the acquisition of these pathogens is paramount for these patients. The goal of this survey was to assess the distribution and the prevalence of the measures adopted for the prevention and control of infections caused by respiratory pathogens in the 28 italian centres for cystic fibrosis. 21 questionnaires were returned and some important differences can be observed in the adoption of segregation measures. Although results may be influenced by other factors, specific segregation policies appear to be more directly associated than other measures (e.g., intensive disinfection; behavioural rules to minimise patient' contacts) with lower prevalence of Pseudomonas aeruginosa (OR 0.36 CI95% 0.31-0.42), of multidrug-resistant Pseudomonas aeruginosa (OR 0.30 CI95% 0.22-0.40), and of methicillin-resistant Staphylococcus aureus (OR 0.67 CI95% 0.48-0.94).
authors.affiliation: Gruppo italiano infermieri di fibrosi cistica, presso Centro regionale veneto fibrosi cistica Verona. f.festini@meyer.it
authors.forename: Filippo
authors.initials: F
authors.lastname: Festini
authors.forename: Silvana
authors.initials: S
authors.lastname: Ballarin
authors.forename: Carmen
authors.initials: C
authors.lastname: Loganes
authors.forename: Teresa
authors.initials: T
authors.lastname: Codamo
authors.forename: Roberta
authors.initials: R
authors.lastname: Doro
authors.forename: Arianna
authors.initials: A
authors.lastname: Adamo
authors.forename: Rita
authors.initials: R
authors.lastname: Adorni
authors.forename: Maria
authors.initials: M
authors.lastname: Cucci
authors.forename: Francesca
authors.initials: F
authors.lastname: Di Marco
authors.forename: Rocchina
authors.initials: R
authors.lastname: Lovallo
authors.forename: Stefania
authors.initials: S
authors.lastname: Omenetti
authors.forename: Rosita
authors.initials: R
authors.lastname: Panebianco
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Pisano
authors.forename: Anna
authors.initials: A
authors.lastname: Russo
authors.forename: Maria Cecilia
authors.initials: MC
authors.lastname: Sciabacucchi
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Zunino
mesh_terms: D000328:Adult; D000391:Air Microbiology; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications* / Q000628:therapy; D004202:Disinfectants / Q000008:administration & dosage; D006235:Hand Disinfection; D006801:Humans; D007558:Italy; D010356:Patient Isolation; D017410:Practice Guidelines as Topic; D012138:Respiratory Therapy; D012141:Respiratory Tract Infections / Q000382:microbiology / Q000517:prevention & control*; D011795:Surveys and Questionnaires
chemical_list: D004202:Disinfectants